Skip to main content
Hadeel Assad, MD, Oncology, Detroit, MI, Karmanos Cancer Center

HadeelAssadMD

Oncology Detroit, MI

Breast Cancer, Cancer Genetics/Cancer Risk Assessment, Hematologic Oncology

Physician

Dr. Assad is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Assad's full profile

Already have an account?

Summary

  • My background in oncology with specific expertise in the diagnosis and treatment of breast cancer as part of a multidisciplinary team has provided me the experience in caring for cancer patients and understanding the importance of not only prolonging life, but also preserving quality of life.

    As PI or CoInvestigator on several university- and research committee funded grants, I have established strong ties with community providers that will make it possible to recruit and track participants over time. I am currently investigating the role of immunotherapy combined with PARP inhibition as a therapeutic option for stage IV breast cancer patients with germline BRCA 1 or 2 mutations who have progressed on first line therapy.

    I am also investigating the use of novel Antibody Drug Conjugates utilizing chemotherapy conjugated to a monoclonal antibody against the Her2 receptor and comparing it to standard first and second line systemic therapy in Her2 positive metastatic breast cancer as part of a clinical trial. I am also involved in Phase 1 Clinical Trials Program at Karmanos Cancer Institute utilizing newly developed therapeutic agents for treatment of various types of solid malignancies. Previously, evaluated the impact of breast cancer diagnosis and treatment on sexual dysfunction in breast cancer survivors, which is an aspect of quality of life that is frequently overlooked, especially in women.

    I have also evaluated follow-up decisions and care after BRCA testing in women with or without personal history of malignancy, given that many risk reduction methods may have profound effects on both cancer recurrence and quality of life. I also investigated socioeconomic differences and informed medical decision making in regards to contralateral prophylactic mastectomy in participants who have had unilateral breast cancer.

Education & Training

  • Ascension Providence/MSUCHM
    Ascension Providence/MSUCHMFellowship, Hematology and Medical Oncology, 2014 - 2017
  • Ascension Providence/MSUCHM
    Ascension Providence/MSUCHMResidency, Internal Medicine, 2011 - 2014
  • University of Jordan Faculty of Medicine
    University of Jordan Faculty of MedicineClass of 2009

Certifications & Licensure

  • MI State Medical License
    MI State Medical License 2011 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Medical Student Excellence Award University of Jordan, School of Medicine, 2009

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Quantitative Assessment of Liver Stiffness Using Ultrasound Shear Wave Elastography in Patients with Chronic Graft‐Versus‐Host Disease After Allogeneic Hematopoietic S...  
    Hadeel Assad, MD, Journal of Ultrasound in Medicine

Press Mentions

  • Graduating Fellow and Karmanos Breast Cancer Specialist Co-Author Manuscript on Triple Negative Breast Cancer with BMT Faculty
    Graduating Fellow and Karmanos Breast Cancer Specialist Co-Author Manuscript on Triple Negative Breast Cancer with BMT FacultyOctober 18th, 2022
  • Registration Open for Breast Cancer Symposium 2020
    Registration Open for Breast Cancer Symposium 2020February 6th, 2020

Grant Support

  • Contralateral prophylactic mastectomy, social economics, and informed medical decision making The major goal of this study is to evaluate the factors that influence women’s decision to undergo contralProvidence Research Committee2015–Present
  • The relationship between serum 27-hydroxycholesterol (27OH) and markers of breast cancer 4 prognosis A pilot study using the Breast Cancer Prognostic study archival tissue bankACS-IRG Grant2018–2019

Professional Memberships

Hospital Affiliations